By Michele Maatouk
Date: Thursday 10 Oct 2019
(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.
No recent information was found.
| GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
| UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
| Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
| Deal speeds drugs sector consolidation | 26-Sep-2006 | The Herald |
No recent information was found.
No recent information was found.
| Currency | Euro |
| Share Price | 263.92 |
| Change Today | 4.42 |
| % Change | 1.70 % |
| 52 Week High | 268.40 |
| 52 Week Low | 129.35 |
| Volume | 74,127 |
| Shares Issued | 190.00m |
| Market Cap | 50,145m |
| Beta | 1.89 |
| Time | Volume / Share Price |
| 16:50 | 11 @ 264.00 |
| 16:50 | 29 @ 264.00 |
| 16:50 | 5 @ 264.00 |
| 16:49 | 46 @ 264.00 |
| 16:49 | 3 @ 264.00 |
You are here: research